✦ LIBER ✦
Dose-intensive adjuvant chemotherapy with epirubicin/paclitaxel vs. epirubicin/cyclophosphamide in breast cancer patients with 4–9/over 9 (second group) positive nodes: preliminary data of this phase II/III trial
✍ Scribed by D. Elling; J. Krocker; S. Kümmel; A. Kohls; J. Heinrich; P. Breitbach; J. Blohmer; W. Lichtenegger
- Book ID
- 117667761
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 133 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.